GNH USA

Europe — EMA

Menopur

GNH USA supplies Menopur (Menotropin), a human menopausal gonadotropin for induction of ovulation and assisted reproductive technology.

Menotrophin

Request sourcing

1
Pack/s

What is Menotrophin?

Menotropin, the active ingredient in Menopur, is a human menopausal gonadotropin (hMG) presented as a lyophilized powder for solution for injection for intramuscular and subcutaneous use. It treats infertility by stimulating follicular development and ovulation in women and spermatogenesis in men.

GNH USA supplies Menopur as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Menotrophin used for?

Menopur (menotropin) is used in reproductive medicine to stimulate gonadal function.

Anovulation in women: induces ovulation to enable conception. Assisted reproductive technology (IVF) cycles: provides controlled ovarian stimulation for egg retrieval. Male hypogonadotropic hypogonadism: stimulates spermatogenesis to improve sperm production.

What are the side effects of Menotrophin?

Menopur may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Injection site reactions: pain, redness, or swelling at the injection site. - Abdominal discomfort: bloating or mild cramping. - Headache: mild to moderate intensity. - Nausea: occasional feeling of queasiness.

Serious or Rare Side Effects: - Ovarian hyperstimulation syndrome (OHSS): rapid ovarian enlargement with fluid shift. - Multiple pregnancy: increased chance of twins or higher‑order gestations. - Thromboembolic events: rare blood clots. - Allergic reaction: rash, urticaria, or anaphylaxis.

What precautions apply to Menotrophin?

Before using Menopur, clinicians should consider several safety measures.

Monitor ovarian response: use ultrasound and estradiol levels to adjust dose. Assess for OHSS risk: avoid in patients with polycystic ovary syndrome or high baseline estradiol. Avoid use in uncontrolled thyroid disease: correct thyroid function before treatment. Review medication history: contraindicated with gonadotropin‑releasing hormone antagonists that may interfere. Pregnancy testing: confirm non‑pregnant status before initiating therapy. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Menotrophin interact with?

Menopur can interact with other medicines that affect hormonal balance or coagulation.

Major Interactions (Avoid): - GnRH antagonists: may blunt the stimulatory effect of menotropin. - Oral contraceptives: suppress endogenous gonadotropins and reduce efficacy. - Corticosteroids: can alter ovarian response.

Moderate Interactions (Monitor Closely): - Thyroid hormone therapy: adjust dose if thyroid status changes. - Anticoagulants: increased risk of bleeding with ovarian enlargement. - Insulin or oral hypoglycemics: monitor glucose if OHSS develops.

Frequently asked questions

What is Menopur used for?+
Menopur is a gonadotropin preparation containing FSH and LH activity, used to stimulate ovarian follicle development and ovulation in women with anovulation, to provide controlled ovarian stimulation in assisted reproductive technology such as IVF, and to promote spermatogenesis in men with hypogonadotropic hypogonadism.
How does menotropin work?+
Menotropin supplies both follicle‑stimulating hormone (FSH) and luteinizing hormone (LH) derived from post‑menopausal urine. After injection, FSH binds to receptors on ovarian granulosa cells, encouraging follicular growth, while LH activates theca cells and luteal tissue to produce steroids, together supporting follicle maturation, ovulation, or sperm production in men.
What is the usual dose of Menopur?+
The dose of Menopur is individualized; a prescribing clinician determines the amount and schedule based on the patient’s ovarian response, body weight, and treatment protocol. Dosing may be adjusted during the stimulation cycle according to ultrasound monitoring and hormone levels.
Is Menopur safe during pregnancy or breastfeeding?+
Menopur is intended for use before conception to induce ovulation; it is not administered during an established pregnancy. Safety data for use while breastfeeding are limited, and the product is generally avoided in nursing mothers unless the benefits outweigh potential risks as assessed by the treating physician.
How do I order Menopur from GNH USA?+
To order Menopur, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details—including cold‑chain handling if needed—and the necessary import documentation.
How does Menopur compare with other fertility drugs?+
Menopur differs from recombinant FSH products by providing a combination of FSH and LH activity in a single preparation, which can simplify dosing for patients who need both hormones. Recombinant preparations offer pure FSH without LH, requiring an additional LH source if needed. Choice depends on clinical protocol, patient response, and physician preference.
How should Menopur be stored and handled?+
Menopur should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the vials in their original packaging until use, and allow the product to reach room temperature briefly before reconstitution, following aseptic technique to maintain sterility.
How is Menopur administered?+
Menopur is supplied as a lyophilized powder that must be reconstituted with a sterile diluent. The resulting solution is injected subcutaneously or intramuscularly, typically in the abdomen or thigh, according to the dosing schedule prescribed by the clinician. Proper injection technique and site rotation help minimize local reactions.
What are the most serious risks to watch for with Menopur?+
The most serious risks include ovarian hyperstimulation syndrome (OHSS), which can cause rapid ovarian enlargement, fluid shifts, and, in severe cases, thromboembolism or renal failure. Multiple pregnancy is another significant concern, as the drug can increase the likelihood of twins or higher‑order gestations. Prompt monitoring is essential to detect these complications early.
Who should not use Menopur?+
Menopur is contraindicated in individuals with known hypersensitivity to menotropin or any component of the formulation, in patients with active ovarian cysts, uncontrolled thyroid disease, or severe ovarian failure. It should also be avoided in women who are already pregnant, have ovarian hyperstimulation syndrome, or have a history of thromboembolic disorders unless a specialist determines the benefits outweigh the risks.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Menotrophin
Route
Intramuscular Use , Subcutaneous Use
Manufacturer
Ferring B.V.
Origin
EU

Related products